Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Could Conservative Treatment Become the New Gold Standard in the Treatment of Acute Achilles Tendon Ruptures: A Prospective Randomized Controlled Trial

NCT07312097 is registered in ClinicalTrials.gov with Haseki Training and Research Hospital as lead sponsor.

NCT NCT07312097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07312097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Could Conservative Treatment Become the New Gold Standard in the Treatment of Acute Achilles Tendon Ruptures: A Prospective Randomized Controlled Trial
Lead sponsor
Haseki Training and Research Hospital
Phase
Not applicable
Overall status
Completed
Start date
August 20, 2023
Completion date
December 20, 2024
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute achilles tendon rupture